Azitra (AZTR) Capital Expenditures (2022 - 2026)
Azitra (AZTR) posted Capital Expenditures of $14928.0 for Q1 2026, up 61.4% on a QoQ basis from $9249.0 in Q4 2025.
Azitra (AZTR) Capital Expenditures (2022 - 2026) Analysis & Trends
Azitra's Capital Expenditures history runs 5 years deep, the most recent figure standing at $14928.0 for Q1 2026.
- Quarterly Capital Expenditures changed N/A year-over-year to $14928.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39141.0 (up 356.77% YoY) and the FY2025 annual result came in at $24213.0, up 182.57% from the prior year.
- Capital Expenditures was $14928.0 for Q1 2026 at Azitra, up from $9249.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $15192.0 in Q4 2022 and bottomed at -$4265.0 in Q2 2023.
- A 5-year average of $9490.8 and a median of $11601.0 in 2025 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures sank 76.95% — and 2024, when it surged 148.67%.
- Azitra's Capital Expenditures stood at $15192.0 in 2022, then slipped by 14.62% to $12971.0 in 2023, then plunged by 33.94% to $8569.0 in 2024, then increased by 7.94% to $9249.0 in 2025, then surged by 61.4% to $14928.0 in 2026.
- Business Quant data shows AZTR's Capital Expenditures at $14928.0 in Q1 2026, $9249.0 in Q4 2025, and $3363.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn | 43.25 Mn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn | 133.40 Mn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn | 230.60 Mn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | 21.83 Mn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - | 786,000.00 |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - | 14,928.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,928.00 |
| Mar 31, 2026 | 14,928.00 |
| Dec 31, 2025 | 9,249.00 |
| Dec 31, 2025 | 9,249.00 |
| Sep 30, 2025 | 3,363.00 |
| Sep 30, 2025 | 3,363.00 |
| Jun 30, 2025 | 11,601.00 |
| Jun 30, 2025 | 11,601.00 |
| Sep 30, 2024 | 8,569.00 |
| Sep 30, 2024 | 8,569.00 |
| Dec 31, 2023 | 12,971.00 |
| Dec 31, 2023 | 12,971.00 |
| Sep 30, 2023 | 3,446.00 |
| Sep 30, 2023 | 3,446.00 |
| Jun 30, 2023 | -4,265.00 |
| Jun 30, 2023 | -4,265.00 |
| Mar 31, 2023 | 14,392.00 |
| Mar 31, 2023 | 14,392.00 |
| Dec 31, 2022 | 15,192.00 |
| Dec 31, 2022 | 15,192.00 |